Haematologica (Oct 2020)
Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab
Abstract
No abstracts available.
Haematologica (Oct 2020)